Prominent Indian investors, including Akash Bhansali and Ashish Dhawan, saw their portfolio values climb by up to 9% in July. This performance significantly outpaced the broader BSE Sensex and Nifty indices, which rose by approximately 1% during the same period. Investors should note that while many portfolios grew, some individual holdings faced volatility, reflecting the selective nature of these market gains.
The portfolios of several high-profile Indian investors demonstrated strong performance in July 2026, delivering returns that significantly beat the major benchmark indices. While the BSE Sensex and Nifty 50 saw modest gains of around 1%, portfolios managed by seasoned investors like Akash Bhansali, Ashish Dhawan, and Mukul Agrawal recorded growth ranging from 4% to 9%. These performance figures are based on publicly disclosed holdings of 1% or more as of the end of the April-June 2026 quarter.
Akash Bhansali Leads Portfolio Growth
Akash Bhansali emerged as a top performer among these investors, with his portfolio value rising to Rs 7,548 crore in July from Rs 6,898 crore at the end of the previous quarter. This 9% increase was largely driven by positive movement in several key holdings. Shares of Laurus Labs, One Communications, Gujarat Fluorochemicals, Sudarshan Chemicals, and Ramkrishna Forgings all saw double-digit gains, ranging between 11% and 20% during the month. This demonstrates the impact that concentrated bets on specific mid-cap and small-cap stocks can have on overall portfolio value when sector sentiment turns positive.
Dhawan and Agrawal See Robust Gains
Ashish Dhawan’s portfolio also saw significant appreciation, growing by 5% to reach Rs 2,741 crore. His investments in financials and business services, including Mahindra & Mahindra Financial Services, Quess Corp, and IIFL Finance, contributed to this performance, with many of these stocks rising between 11% and 15% over the recent period. Similarly, Mukul Mahavir Agrawal reported a 4.6% increase in his portfolio value to Rs 6,925 crore. His portfolio showed high volatility, with 15 stocks posting gains of over 10%. Notable winners in his portfolio included Tatva Chintan Pharma Chem, MPS, and Zelio E-Mobility, which recorded advances of 31% to 50%.
Diverse Market Results and Risks
Not all high-profile portfolios mirrored these gains. Ashish Kacholia’s portfolio experienced a slight decline of 0.41% in July, with his holdings totaling Rs 2,440 crore. This dip highlights the risks associated with small-cap and niche investments, as several of his holdings—such as Aeroflex, Man Industries, C2C Advanced Systems, and Z-Tech—declined between 10% and 31% during the month. This divergence illustrates that even seasoned investors face periods of underperformance depending on their specific stock selection.
Outlook and Market Context
While these portfolios have outperformed in the short term, broader market conditions remain uncertain. Analysts are monitoring geopolitical developments in West Asia and their potential effect on global crude oil prices, which can influence domestic inflation and corporate profit margins. Future performance will depend heavily on corporate earnings growth and the ability of companies to manage balance sheet strength in a volatile environment. Investors looking at these portfolios should track management quality and valuation comfort rather than focusing solely on short-term price movements, as market consolidation remains a possibility if macro pressures persist.